Fennec Pharmaceuticals Inc. (FENC)
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
$145.28M
Mr. Rostislav Raykov
10.00
Research Triangle Park, NC
Jun 05, 2001
75.86
$0.07
5.56
8.02
1.85%
5.43%
53.94
-0.25
-105.82
2.93
7.75
4.22%
-52.10%
Similar stocks (13)
Edgewise Therapeutics, Inc.
EWTX
Janux Therapeutics, Inc.
JANX
Harmony Biosciences Holdings, Inc.
HRMY
Keros Therapeutics, Inc.
KROS
Disc Medicine, Inc.
IRON
Olema Pharmaceuticals, Inc.
OLMA
Eliem Therapeutics, Inc.
ELYM
Larimar Therapeutics, Inc.
LRMR
MediciNova, Inc.
MNOV
Ikena Oncology, Inc.
IKNA
Champions Oncology, Inc.
CSBR
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
ETF Exposure (19)
iShares Micro-Cap ETF
IWC
0.03422%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00729%
iShares Russell 2000 ETF
IWM
0.00456%
ProShares Ultra Russell2000
UWM
0.0018645947432655867%
iShares Russell 2000 Growth ETF
IWO
0.00183%
ProShares UltraPro Russell2000
URTY
9.198260407598713e-4%
ProShares Hedge Replication ETF
HDG
7.712006948561345e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Similar stocks (13)
Edgewise Therapeutics, Inc.
EWTX
Janux Therapeutics, Inc.
JANX
Harmony Biosciences Holdings, Inc.
HRMY
Keros Therapeutics, Inc.
KROS
Disc Medicine, Inc.
IRON
Olema Pharmaceuticals, Inc.
OLMA
Eliem Therapeutics, Inc.
ELYM
Larimar Therapeutics, Inc.
LRMR
MediciNova, Inc.
MNOV
Ikena Oncology, Inc.
IKNA
Champions Oncology, Inc.
CSBR
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
ETF Exposure (19)
iShares Micro-Cap ETF
IWC
0.03422%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00729%
iShares Russell 2000 ETF
IWM
0.00456%
ProShares Ultra Russell2000
UWM
0.0018645947432655867%
iShares Russell 2000 Growth ETF
IWO
0.00183%
ProShares UltraPro Russell2000
URTY
9.198260407598713e-4%
ProShares Hedge Replication ETF
HDG
7.712006948561345e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%